Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 66

    1.

    Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson disease.

    Hoops S, Nazem S, Siderowf AD, Duda JE, Xie SX, Stern MB, Weintraub D.

    Neurology. 2009 Nov 24;73(21):1738-45.PMID: 19933974 [PubMed - in process]

    2.

    Premotor Parkinson's disease: clinical features and detection strategies.

    Stephenson R, Siderowf A, Stern MB.

    Mov Disord. 2009;24 Suppl 2:S665-70.PMID: 19877244 [PubMed - in process]

    3.

    Use of latent variable modeling to delineate psychiatric and cognitive profiles in Parkinson disease.

    Mavandadi S, Nazem S, Ten Have TR, Siderowf AD, Duda JE, Stern MB, Weintraub D.

    Am J Geriatr Psychiatry. 2009 Nov;17(11):986-95.PMID: 19855199 [PubMed - in process]Related articles

    4.

    Treatment disparities in Parkinson's disease.

    Dahodwala N, Xie M, Noll E, Siderowf A, Mandell DS.

    Ann Neurol. 2009 Aug;66(2):142-5.PMID: 19743462 [PubMed - indexed for MEDLINE]Related articles

    5.

    Validation of the questionnaire for impulsive-compulsive disorders in Parkinson's disease.

    Weintraub D, Hoops S, Shea JA, Lyons KE, Pahwa R, Driver-Dunckley ED, Adler CH, Potenza MN, Miyasaki J, Siderowf AD, Duda JE, Hurtig HI, Colcher A, Horn SS, Stern MB, Voon V.

    Mov Disord. 2009 Jul 30;24(10):1461-7.PMID: 19452562 [PubMed - indexed for MEDLINE]Related articles

    6.

    Racial differences in the diagnosis of Parkinson's disease.

    Dahodwala N, Siderowf A, Xie M, Noll E, Stern M, Mandell DS.

    Mov Disord. 2009 Jun 15;24(8):1200-5.PMID: 19412929 [PubMed - indexed for MEDLINE]Related articles

    7.

    Montreal cognitive assessment performance in patients with Parkinson's disease with "normal" global cognition according to mini-mental state examination score.

    Nazem S, Siderowf AD, Duda JE, Have TT, Colcher A, Horn SS, Moberg PJ, Wilkinson JR, Hurtig HI, Stern MB, Weintraub D.

    J Am Geriatr Soc. 2009 Feb;57(2):304-8. Epub 2008 Dec 10.PMID: 19170786 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Amyotrophic lateral sclerosis-plus syndrome with TAR DNA-binding protein-43 pathology.

    McCluskey LF, Elman LB, Martinez-Lage M, Van Deerlin V, Yuan W, Clay D, Siderowf A, Trojanowski JQ.

    Arch Neurol. 2009 Jan;66(1):121-4.PMID: 19139310 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Premotor Parkinson's disease: clinical features, detection, and prospects for treatment.

    Siderowf A, Stern MB.

    Ann Neurol. 2008 Dec;64 Suppl 2:S139-47.PMID: 19127581 [PubMed - indexed for MEDLINE]Related articles

    10.

    Optimal frequency for measuring health care resource utilization in Parkinson's disease using participant recall: the FS-TOO resource utilization substudy.

    Mauldin PD, Guimaraes P, Albin RL, Ray Dorsey E, Bainbridge JL, Siderowf A; NINDS NET-PD Investigators.

    Clin Ther. 2008 Aug;30(8):1553-7.PMID: 18803996 [PubMed - indexed for MEDLINE]Related articles

    11.

    Suicidal and death ideation in Parkinson's disease.

    Nazem S, Siderowf AD, Duda JE, Brown GK, Ten Have T, Stern MB, Weintraub D.

    Mov Disord. 2008 Aug 15;23(11):1573-9.PMID: 18618660 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Mild cognitive impairment is common in Parkinson's disease patients with normal Mini-Mental State Examination (MMSE) scores.

    Mamikonyan E, Moberg PJ, Siderowf A, Duda JE, Have TT, Hurtig HI, Stern MB, Weintraub D.

    Parkinsonism Relat Disord. 2009 Mar;15(3):226-31. Epub 2008 Jul 2.PMID: 18595765 [PubMed - indexed for MEDLINE]Related articles

    13.

    F2 isoprostane levels in plasma and urine do not support increased lipid peroxidation in cognitively impaired Parkinson disease patients.

    Connolly J, Siderowf A, Clark CM, Mu D, Pratico D.

    Cogn Behav Neurol. 2008 Jun;21(2):83-6.PMID: 18541983 [PubMed - indexed for MEDLINE]Related articles

    14.

    Cognitive impairment in Parkinson's disease and dementia with lewy bodies: a spectrum of disease.

    Goldmann Gross R, Siderowf A, Hurtig HI.

    Neurosignals. 2008;16(1):24-34. Epub 2007 Dec 5. Review.PMID: 18097157 [PubMed - indexed for MEDLINE]Related articles

    15.

    Long-term follow-up of impulse control disorders in Parkinson's disease.

    Mamikonyan E, Siderowf AD, Duda JE, Potenza MN, Horn S, Stern MB, Weintraub D.

    Mov Disord. 2008 Jan;23(1):75-80.PMID: 17960796 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Risk factors for Parkinson's disease and impaired olfaction in relatives of patients with Parkinson's disease.

    Siderowf A, Jennings D, Connolly J, Doty RL, Marek K, Stern MB.

    Mov Disord. 2007 Nov 15;22(15):2249-55.PMID: 17876851 [PubMed - indexed for MEDLINE]Related articles

    17.

    Disparities of care in veterans with Parkinson's disease.

    Cheng EM, Siderowf AD, Swarztrauber K, Lee M, Vassar S, Jacob E, Eisa MS, Vickrey BG.

    Parkinsonism Relat Disord. 2008;14(1):8-14. Epub 2007 Aug 16.PMID: 17702625 [PubMed - indexed for MEDLINE]Related articles

    18.

    Co-morbidity of TDP-43 proteinopathy in Lewy body related diseases.

    Nakashima-Yasuda H, Uryu K, Robinson J, Xie SX, Hurtig H, Duda JE, Arnold SE, Siderowf A, Grossman M, Leverenz JB, Woltjer R, Lopez OL, Hamilton R, Tsuang DW, Galasko D, Masliah E, Kaye J, Clark CM, Montine TJ, Lee VM, Trojanowski JQ.

    Acta Neuropathol. 2007 Sep;114(3):221-9. Epub 2007 Jul 25.PMID: 17653732 [PubMed - indexed for MEDLINE]Related articles

    19.

    Differences in depression symptoms in patients with Alzheimer's and Parkinson's diseases: evidence from the 15-item Geriatric Depression Scale (GDS-15).

    Weintraub D, Xie S, Karlawish J, Siderowf A.

    Int J Geriatr Psychiatry. 2007 Oct;22(10):1025-30.PMID: 17562521 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Interest in predictive testing for Parkinson's disease: impact of neuroprotective therapy.

    Dahodwala N, Connolly J, Farmer J, Stern MB, Jennings D, Siderowf A.

    Parkinsonism Relat Disord. 2007 Dec;13(8):495-9. Epub 2007 Apr 20.PMID: 17449316 [PubMed - indexed for MEDLINE]Related articles

    21.

    Association of specialist involvement and quality of care for Parkinson's disease.

    Cheng EM, Swarztrauber K, Siderowf AD, Eisa MS, Lee M, Vassar S, Jacob E, Vickrey BG.

    Mov Disord. 2007 Mar 15;22(4):515-22.PMID: 17260340 [PubMed - indexed for MEDLINE]Related articles

    22.

    Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030.

    Dorsey ER, Constantinescu R, Thompson JP, Biglan KM, Holloway RG, Kieburtz K, Marshall FJ, Ravina BM, Schifitto G, Siderowf A, Tanner CM.

    Neurology. 2007 Jan 30;68(5):384-6. Epub 2006 Nov 2.PMID: 17082464 [PubMed - indexed for MEDLINE]Related articles

    23.

    Long-term outcomes of bilateral subthalamic nucleus stimulation in patients with advanced Parkinson's disease.

    Liang GS, Chou KL, Baltuch GH, Jaggi JL, Loveland-Jones C, Leng L, Maccarone H, Hurtig HI, Colcher A, Stern MB, Kleiner-Fisman G, Simuni T, Siderowf AD.

    Stereotact Funct Neurosurg. 2006;84(5-6):221-7. Epub 2006 Oct 23.PMID: 17063043 [PubMed - indexed for MEDLINE]Related articles

    24.

    Association of dopamine agonist use with impulse control disorders in Parkinson disease.

    Weintraub D, Siderowf AD, Potenza MN, Goveas J, Morales KH, Duda JE, Moberg PJ, Stern MB.

    Arch Neurol. 2006 Jul;63(7):969-73.PMID: 16831966 [PubMed - indexed for MEDLINE]Related articlesFree article

    25.

    Preclinical diagnosis of Parkinson's disease: are we there yet?

    Siderowf A, Stern MB.

    Curr Neurol Neurosci Rep. 2006 Jul;6(4):295-301. Review.PMID: 16822349 [PubMed - indexed for MEDLINE]Related articles

    26.

    Clinical trials with rasagiline: evidence for short-term and long-term effects.

    Siderowf A, Stern M.

    Neurology. 2006 May 23;66(10 Suppl 4):S80-8.PMID: 16717255 [PubMed - indexed for MEDLINE]Related articles

    27.

    Long-term effects of bilateral subthalamic nucleus stimulation on health-related quality of life in advanced Parkinson's disease.

    Siderowf A, Jaggi JL, Xie SX, Loveland-Jones C, Leng L, Hurtig H, Colcher A, Stern M, Chou KL, Liang G, Maccarone H, Simuni T, Baltuch G.

    Mov Disord. 2006 Jun;21(6):746-53.PMID: 16463342 [PubMed - indexed for MEDLINE]Related articles

    28.

    Rasagiline improves quality of life in patients with early Parkinson's disease.

    Biglan KM, Schwid S, Eberly S, Blindauer K, Fahn S, Goren T, Kieburtz K, Oakes D, Plumb S, Siderowf A, Stern M, Shoulson I; Parkinson Study Group.

    Mov Disord. 2006 May;21(5):616-23.PMID: 16450340 [PubMed - indexed for MEDLINE]Related articles

    29.

    Venous thrombosis in an ALS population over four years.

    Elman LB, Siderowf A, Houseman G, Kelley M, McCluskey LF.

    Amyotroph Lateral Scler Other Motor Neuron Disord. 2005 Dec;6(4):246-9.PMID: 16319029 [PubMed - indexed for MEDLINE]Related articles

    30.

    Donepezil for dementia in Parkinson's disease: a randomised, double blind, placebo controlled, crossover study.

    Ravina B, Putt M, Siderowf A, Farrar JT, Gillespie M, Crawley A, Fernandez HH, Trieschmann MM, Reichwein S, Simuni T.

    J Neurol Neurosurg Psychiatry. 2005 Jul;76(7):934-9.PMID: 15965198 [PubMed - indexed for MEDLINE]Related articlesFree article

    31.

    [99mTc]TRODAT-1 SPECT imaging correlates with odor identification in early Parkinson disease.

    Siderowf A, Newberg A, Chou KL, Lloyd M, Colcher A, Hurtig HI, Stern MB, Doty RL, Mozley PD, Wintering N, Duda JE, Weintraub D, Moberg PJ.

    Neurology. 2005 May 24;64(10):1716-20.PMID: 15911797 [PubMed - indexed for MEDLINE]Related articles

    32.

    Differences in [99mTc]TRODAT-1 SPECT binding to dopamine transporters in patients with multiple system atrophy and Parkinson's disease.

    Swanson RL, Newberg AB, Acton PD, Siderowf A, Wintering N, Alavi A, Mozley PD, Plossl K, Udeshi M, Hurtig H.

    Eur J Nucl Med Mol Imaging. 2005 Mar;32(3):302-7. Epub 2004 Oct 2.PMID: 15791439 [PubMed - indexed for MEDLINE]Related articles

    33.

    Evidence from clinical trials: can we do better?

    Siderowf AD.

    NeuroRx. 2004 Jul;1(3):363-71. Review.PMID: 15717039 [PubMed - indexed for MEDLINE]Related articlesFree article

    34.

    Evidence-based neurotherapeutics: a spectrum of evidence.

    Holloway RG, Siderowf AD.

    NeuroRx. 2004 Jul;1(3):295-7. No abstract available. PMID: 15717030 [PubMed - indexed for MEDLINE]Related articlesFree article

    35.

    Striatal dopamine transporter imaging correlates with anxiety and depression symptoms in Parkinson's disease.

    Weintraub D, Newberg AB, Cary MS, Siderowf AD, Moberg PJ, Kleiner-Fisman G, Duda JE, Stern MB, Mozley D, Katz IR.

    J Nucl Med. 2005 Feb;46(2):227-32.PMID: 15695780 [PubMed - indexed for MEDLINE]Related articlesFree article

    36.

    Multiple pathologies in a patient with a progressive neurodegenerative syndrome.

    Liang TW, Forman MS, Duda JE, McCluskey L, Trojanowski JQ, Siderowf A.

    J Neurol Neurosurg Psychiatry. 2005 Feb;76(2):252-5.PMID: 15654043 [PubMed - indexed for MEDLINE]Related articlesFree article

    37.

    Breaking the news: a survey of ALS patients and their caregivers.

    McCluskey L, Casarett D, Siderowf A.

    Amyotroph Lateral Scler Other Motor Neuron Disord. 2004 Sep;5(3):131-5.PMID: 15512900 [PubMed - indexed for MEDLINE]Related articles

    38.

    Unilateral battery depletion in Parkinson's disease patients treated with bilateral subthalamic nucleus deep brain stimulation may require urgent surgical replacement.

    Chou KL, Siderowf AD, Jaggi JL, Liang GS, Baltuch GH.

    Stereotact Funct Neurosurg. 2004;82(4):153-5. Epub 2004 Oct 5.PMID: 15475657 [PubMed - indexed for MEDLINE]Related articles

    39.

    Bilateral stimulation of the subthalamic nucleus in Parkinson's disease: surgical efficacy and prediction of outcome.

    Jaggi JL, Umemura A, Hurtig HI, Siderowf AD, Colcher A, Stern MB, Baltuch GH.

    Stereotact Funct Neurosurg. 2004;82(2-3):104-14. Epub 2004 Apr 26.PMID: 15305083 [PubMed - indexed for MEDLINE]Related articles

    40.

    Diagnostic accuracy of [99mTc]TRODAT-1 SPECT imaging in early Parkinson's disease.

    Chou KL, Hurtig HI, Stern MB, Colcher A, Ravina B, Newberg A, Mozley PD, Siderowf A.

    Parkinsonism Relat Disord. 2004 Aug;10(6):375-9.PMID: 15261880 [PubMed - indexed for MEDLINE]Related articles

    41.

    Development of quality of care indicators for Parkinson's disease.

    Cheng EM, Siderowf A, Swarztrauber K, Eisa M, Lee M, Vickrey BG.

    Mov Disord. 2004 Feb;19(2):136-50. Review.PMID: 14978668 [PubMed - indexed for MEDLINE]Related articles

    42.

    Nocturnal oximetry: utility in the respiratory management of amyotrophic lateral sclerosis.

    Elman LB, Siderowf AD, McCluskey LF.

    Am J Phys Med Rehabil. 2003 Nov;82(11):866-70.PMID: 14566155 [PubMed - indexed for MEDLINE]Related articles

    43.

    Diagnosis and treatment of Parkinson's disease: a systematic review of the literature.

    Levine CB, Fahrbach KR, Siderowf AD, Estok RP, Ludensky VM, Ross SD.

    Evid Rep Technol Assess (Summ). 2003 May;(57):1-4. Review. No abstract available. PMID: 12841131 [PubMed - indexed for MEDLINE]Related articles

    44.

    Lack of effect of polymorphisms in dopamine metabolism related genes on imaging of TRODAT-1 in striatum of asymptomatic volunteers and patients with Parkinson's disease.

    Lynch DR, Mozley PD, Sokol S, Maas NM, Balcer LJ, Siderowf AD.

    Mov Disord. 2003 Jul;18(7):804-12.PMID: 12815660 [PubMed - indexed for MEDLINE]Related articles

    45.

    Update on Parkinson disease.

    Siderowf A, Stern M.

    Ann Intern Med. 2003 Apr 15;138(8):651-8. Review.PMID: 12693888 [PubMed - indexed for MEDLINE]Related articlesFree article

    46.

    Deep brain stimulation for movement disorders: morbidity and mortality in 109 patients.

    Umemura A, Jaggi JL, Hurtig HI, Siderowf AD, Colcher A, Stern MB, Baltuch GH.

    J Neurosurg. 2003 Apr;98(4):779-84.PMID: 12691402 [PubMed - indexed for MEDLINE]Related articles

    47.

    Progressive supranuclear palsy: Setting the scene for therapeutic trials.

    Siderowf A, Quinn NP.

    Neurology. 2003 Mar 25;60(6):892-3. No abstract available. PMID: 12654948 [PubMed - indexed for MEDLINE]Related articles

    48.

    Test-retest reliability of the unified Parkinson's disease rating scale in patients with early Parkinson's disease: results from a multicenter clinical trial.

    Siderowf A, McDermott M, Kieburtz K, Blindauer K, Plumb S, Shoulson I; Parkinson Study Group.

    Mov Disord. 2002 Jul;17(4):758-63.PMID: 12210871 [PubMed - indexed for MEDLINE]Related articles

    49.

    Preference-based quality-of-life in patients with Parkinson's disease.

    Siderowf A, Ravina B, Glick HA.

    Neurology. 2002 Jul 9;59(1):103-8.PMID: 12105315 [PubMed - indexed for MEDLINE]Related articles

    50.

    Bilateral stimulation of the subthalamic nucleus in patients with Parkinson disease: a study of efficacy and safety.

    Simuni T, Jaggi JL, Mulholland H, Hurtig HI, Colcher A, Siderowf AD, Ravina B, Skolnick BE, Goldstein R, Stern MB, Baltuch GH.

    J Neurosurg. 2002 Apr;96(4):666-72.PMID: 11990805 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...